India, Oct. 22 -- Indegene has received Frost & Sullivan's 2026 Global Enabling Technology Leadership Recognition for its AI-powered pharmaceutical commercialisation services, acknowledging its achievements in workflow transformation, technology innovation and customer value creation.
The recognition follows a benchmarking assessment of strategy effectiveness and execution, in which Indegene demonstrated its ability to scale AI-driven solutions across commercial, medical, regulatory, safety, analytics, content and field engagement workflows.
The company's Pharma Operating System (OS) integrates business decisions, workflow execution and enterprise intelligence, helping pharmaceutical organisations replace fragmented processes with connect...